VRSN Form 144: Proposed Sale of 700 Shares Valued at $189,000
Form 144 filed for VeriSign, Inc. (VRSN) reports a proposed sale of 700 shares of Common stock through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $189,000.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Form 144 filed for VeriSign, Inc. (VRSN) reports a proposed sale of 700 shares of Common stock through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $189,000. The shares were acquired on 07/22/2024 via restricted stock vesting under a registered plan and were paid as services rendered. The filing shows 93,408,594 shares outstanding for the class and an approximate sale date of 08/20/2025. No other sales in the past three months were reported. The filer certifies they are unaware of undisclosed material adverse information.
Insights
TL;DR: Small insider sale reported; transaction appears routine and not material to VRSN's capitalization.
The notice documents a planned sale of 700 restricted shares vested in July 2024, executed via a broker on NASDAQ with aggregate value reported at $189,000. Against the reported 93,408,594 shares outstanding, this size is immaterial to market capitalization. The filing complies with Rule 144 disclosure requirements and shows no other insider disposals in the last three months. This is a standard compliance filing rather than a signal of company-wide developments.
TL;DR: Routine insider disposition under Rule 144; governance disclosure appears complete and customary.
The submitter discloses acquisition details (restricted stock vesting) and payment nature (services rendered), meeting Rule 144 transparency expectations. The signature attestation about no undisclosed material adverse information is included. There are no indications of coordinated large-scale selling or other governance red flags in this filing. Documentation supports routine management or employee liquidity activity consistent with registered-plan vesting.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does VeriSign's Form 144 (VRSN) report?
Who is the broker handling the proposed sale in the VRSN Form 144?
Does the Form 144 show other securities sold by the seller in the past three months?
AI-generated analysis. How Rhea-AI works. Not financial advice.